These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36959411)

  • 1. Computational Model of In Vivo Corneal Pharmacokinetics and Pharmacodynamics of Topically Administered Ophthalmic Drug Products.
    German C; Chen Z; Przekwas A; Walenga R; Babiskin A; Zhao L; Fan J; Tan ML
    Pharm Res; 2023 Apr; 40(4):961-975. PubMed ID: 36959411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye.
    Fayyaz A; Vellonen KS; Ranta VP; Toropainen E; Reinisalo M; Valtari A; Puranen J; Ricci GD; Heikkinen EM; Gardner I; Ruponen M; Urtti A; Jamei M; Del Amo EM
    Eur J Pharm Biopharm; 2021 Sep; 166():155-162. PubMed ID: 34139290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-dark variations in ocular timolol concentrations following topical solution instillation in the pigmented rabbit.
    Ohdo S; Zhu J; Lee VH
    Life Sci; 1992; 51(26):2025-31. PubMed ID: 1474859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
    Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
    Biol Pharm Bull; 2008 Aug; 31(8):1590-5. PubMed ID: 18670094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular pharmacokinetic/pharmacodynamic modeling for timolol in rabbits using a telemetry system.
    Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
    Biol Pharm Bull; 2008 May; 31(5):970-5. PubMed ID: 18451528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model.
    Moosa RM; Choonara YE; du Toit LC; Tomar LK; Tyagi C; Kumar P; Carmichael TR; Pillay V
    Int J Pharm; 2014 May; 466(1-2):296-306. PubMed ID: 24607446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
    Ohdo S; Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for evaluation of topical ophthalmic drug products in different compartments of fresh eye tissues in a rabbit model.
    Chockalingam A; Xu L; Stewart S; LeMerdy M; Tsakalozou E; Fan J; Patel V; Rouse R
    J Pharmacol Toxicol Methods; 2019; 96():9-14. PubMed ID: 30552958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Assessment of Distribution Characteristics and Ocular Pharmacokinetics of Norvancomycin Between Continuous Topical Ocular Instillation and Hourly Administration of Eye Drop.
    Lin W; Zhao L; Huang X; Tan Q; Peng M; Khan MA; Lin D
    Drug Des Devel Ther; 2020; 14():867-879. PubMed ID: 32161446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo.
    Qin F; Zeng L; Zhu Y; Cao J; Wang X; Liu W
    Drug Dev Ind Pharm; 2016; 42(4):535-45. PubMed ID: 26368660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
    Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Study of Ocular Pharmacokinetics of Gatifloxacin Between Continuous Lavage and Hourly Topical Instillation in Rabbits.
    Zhao X; Shen X; Zhang X; Chen S; Lu H; Wang M
    Cornea; 2018 Nov; 37(11):1457-1462. PubMed ID: 30124589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes.
    Fukuda M; Sasaki H
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):57-60. PubMed ID: 25303115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits.
    Fayyaz A; Ranta VP; Toropainen E; Vellonen KS; Valtari A; Puranen J; Ruponen M; Gardner I; Urtti A; Jamei M; Del Amo EM
    Eur J Pharm Sci; 2020 Dec; 155():105553. PubMed ID: 32946960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
    Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A compartment model to calculate time-dependent concentration profiles of topically applied chemical compounds in the anterior compartments of the rabbit eye.
    Pospisil H; Holzhütter HG
    Altern Lab Anim; 2001; 29(3):347-65. PubMed ID: 11387029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics of timolol in the rabbit lens: implications for ocular drug delivery.
    Ahmed I; Francoeur ML; Thombre AG; Patton TF
    Pharm Res; 1989 Sep; 6(9):772-8. PubMed ID: 2813274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment.
    Lancina MG; Wang J; Williamson GS; Yang H
    Mol Pharm; 2018 Jul; 15(7):2883-2889. PubMed ID: 29767982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of ocular timolol: drug concentrations and beta-receptor binding activity in the aqueous humour of the treated and contralateral eye.
    Saari KM; Ali-Melkkilä T; Vuori ML; Kaila T; Iisalo E
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):671-6. PubMed ID: 7906472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.